Danaher Corporation $DHR Stock: McKinley Carter Wealth Services Inc. Increases Position

by · The Markets Daily

McKinley Carter Wealth Services Inc. lifted its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 354.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 5,051 shares of the conglomerate’s stock after acquiring an additional 3,940 shares during the period. McKinley Carter Wealth Services Inc.’s holdings in Danaher were worth $1,119,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the business. Gunderson Capital Management LLC purchased a new position in shares of Danaher during the third quarter valued at about $765,000. EP Wealth Advisors LLC bought a new stake in shares of Danaher in the second quarter worth about $3,807,000. Banque Pictet & Cie SA increased its holdings in shares of Danaher by 23.4% in the third quarter. Banque Pictet & Cie SA now owns 145,326 shares of the conglomerate’s stock worth $32,197,000 after purchasing an additional 27,534 shares during the last quarter. Baugh & Associates LLC purchased a new stake in shares of Danaher in the third quarter worth about $16,100,000. Finally, Puzo Michael J purchased a new stake in shares of Danaher in the second quarter worth about $8,624,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of NYSE:DHR opened at $228.87 on Friday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The stock has a market capitalization of $160.89 billion, a P/E ratio of 40.65, a PEG ratio of 2.88 and a beta of 0.76. The firm has a fifty day simple moving average of $214.04 and a two-hundred day simple moving average of $195.97. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.77 EPS. On average, analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 28.42%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research reports. Guggenheim increased their price target on Danaher from $200.00 to $250.00 and gave the company a “buy” rating in a research note on Thursday, October 1st. Weiss Ratings upgraded Danaher from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, September 16th. Barclays lifted their price objective on Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. Royal Bank Of Canada upped their price objective on Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a report on Monday, October 5th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Two research analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $235.41.

Check Out Our Latest Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.

Read More